ArticleOncotarget2017

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.

Tarek M A Abdel-Fatah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.